Form 4 for RCEL AVITA Medical, Inc.
Accepted 2024-06-06 00:00:00 ET · period of report 2024-06-05 · accession 0000950170-24-070096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-06 | 2024-06-05 | RCEL | McNamara Robert | Dir | A - Grant | — | +9,200 | 25.7K | +56% | — |
| D | 2024-06-06 | 2024-06-05 | RCEL | McNamara Robert | Dir | A - Grant | $0.00 | +3,943 | 3,943 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | A | A | 9,200 | — | 25,749 | D | — | — | (F1) Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date. (F2) Includes unvested RSUs. |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-06-05 | A | A | 3,943 | $0.00 | 3,943 | D | $9.51 · 2025-06-05 to 2034-06-05 | 3,943 Common Stock |